Your browser doesn't support javascript.
loading
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.
Nemati, Fariba; de Koning, Leanne; Gentien, David; Assayag, Franck; Henry, Emilie; Ait Rais, Khadija; Pierron, Gaelle; Mariani, Odette; Nijnikoff, Michèle; Champenois, Gabriel; Nicolas, André; Meseure, Didier; Gardrat, Sophie; Servant, Nicolas; Hupé, Philippe; Kamal, Maud; Le Tourneau, Christophe; Piperno-Neumann, Sophie; Rodrigues, Manuel; Roman-Roman, Sergio; Decaudin, Didier; Mariani, Pascale; Cassoux, Nathalie.
Affiliation
  • Nemati F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University Paris, 26 rue d'Ulm, CEDEX 05, 75248 Paris, France.
  • de Koning L; Translational Research Department, Institut Curie, PSL University Paris, 75248 Paris, France.
  • Gentien D; Genomics Platform, Translational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.
  • Assayag F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University Paris, 26 rue d'Ulm, CEDEX 05, 75248 Paris, France.
  • Henry E; Genomics Platform, Translational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.
  • Ait Rais K; Department of Genetics, Institut Curie, PSL Research University, 75248 Paris, France.
  • Pierron G; Department of Genetics, Institut Curie, PSL Research University, 75248 Paris, France.
  • Mariani O; Biological Resource Center, Department of Pathology, Institut Curie, PSL Research University, 75248 Paris, France.
  • Nijnikoff M; Biological Resource Center, Department of Pathology, Institut Curie, PSL Research University, 75248 Paris, France.
  • Champenois G; Department of Biopathology, Institut Curie, PSL Research University, 75248 Paris, France.
  • Nicolas A; Department of Biopathology, Institut Curie, PSL Research University, 75248 Paris, France.
  • Meseure D; Department of Biopathology, Institut Curie, PSL Research University, 75248 Paris, France.
  • Gardrat S; Department of Biopathology, Institut Curie, PSL Research University, 75248 Paris, France.
  • Servant N; Institut Curie, INSERM U900, CBIO-Centre for Computational Biology, Mines Paris Tech, PSL-Research University, 75248 Paris, France.
  • Hupé P; Institut Curie, INSERM U900, CBIO-Centre for Computational Biology, Mines Paris Tech, PSL-Research University, 75248 Paris, France.
  • Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, 75248 Paris, France.
  • Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, 75248 Paris, France.
  • Piperno-Neumann S; INSERM U900 Research Unit, Institut Curie, 92064 Saint-Cloud, France.
  • Rodrigues M; Paris-Saclay University, 75248 Paris, France.
  • Roman-Roman S; Department of Medical Oncology, Institut Curie, PSL Research University, 75248 Paris, France.
  • Decaudin D; Department of Medical Oncology, Institut Curie, PSL Research University, 75248 Paris, France.
  • Mariani P; Translational Research Department, Institut Curie, PSL University Paris, 75248 Paris, France.
  • Cassoux N; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University Paris, 26 rue d'Ulm, CEDEX 05, 75248 Paris, France.
Curr Oncol ; 30(10): 9090-9103, 2023 10 11.
Article in En | MEDLINE | ID: mdl-37887557

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Neoplasms / Neoplasm Recurrence, Local Limits: Adult / Animals / Humans Language: En Journal: Curr Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Neoplasms / Neoplasm Recurrence, Local Limits: Adult / Animals / Humans Language: En Journal: Curr Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: